A new in vitro method to predict in vivo photoprotection of skin hyperpigmentation induced by visible light
- PMID: 35224781
- PMCID: PMC9314032
- DOI: 10.1111/jdv.18034
A new in vitro method to predict in vivo photoprotection of skin hyperpigmentation induced by visible light
Abstract
Background: Ultraviolet radiation is the main cause of skin pigmentation, but more recently visible light has been shown to be an important contributor especially in melano-competent subjects. Photoprotection from visible light can improve several hyperpigmentation disorders. Recently, a visible light photoprotection assessment method has been proposed based on in vivo pigmentation; the visible light photoprotection factor (VL-PF) is determined by assessment of the change in colorimetry parameter ITA over several days measured using a chromameter. Although in vivo methods remain the most representative of real life, in vitro methods are more suited to screening sunscreen formulations.
Objective: The aim of this study was to evaluate the correlation between in vivo and in vitro methods in assessing protection against visible light induced pigmentation.
Methods: We first analysed the in vitro protective properties of the 10 commercially available sunscreens using transmission measurements in the visible spectrum. Then, we performed a monocentric, double-blind, randomized controlled study with intra-individual comparisons in 20 healthy subjects and measure the VL-PF in vivo of those sunscreens. The correlation between the VL-PF and the percentage of blocked light was evaluated using the coefficient of determination R2 .
Results: A strong significant correlation was demonstrated between in vivo visible light protection factor and in vitro transmittance measurements, with the highest correlation factor at 420 nm and in the spectrum covering from 400 to 469 nm.
Conclusion: Transmittance measurements were found to be a good predictive tool to evaluate sunscreen visible light photoprotection efficacy and could be used to select formulations for final in vivo testing.
© 2022 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Figures
References
-
- Duteil L, Cardot‐Leccia N, Queille‐Roussel C et al. Differences in visible light‐induced pigmentation according to wavelengths: A clinical and histological study in comparison with UVB exposure. Pigment Cell Melanoma Res 2014; 27: 822–826. - PubMed
-
- Mahmoud BH, Ruvolo E, Hexsel CL et al. Impact of long‐wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol 2010; 130: 2092–2097. - PubMed
-
- Duteil L, Esdaile J, Maubert Y et al. A method to assess the protective efficacy of sunscreens against visible light‐induced pigmentation. Photodermatol Photoimmunol Photomed 2017; 33: 260–266. - PubMed
-
- Boukari F, Jourdan E, Fontas E et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: A prospective randomized comparative trial. J Am Acad Dermatol 2015; 72: 189–190. - PubMed
-
- Castanedo‐Cazares JP, Hernandez‐Blanco D, Carlos‐Ortega B, Fuentes‐Ahumada C, Torres‐Álvarez B. Near‐visible light and UV photoprotection in the treatment of melasma: A double‐blind randomized trial. Photodermatol Photoimmunol Photomed 2014; 30: 35–42. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
